Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05624749 |
|---|---|
| Brief Title: | Phase 3 Study to Evaluate Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 2) (SIRIUS-SLE 2) |
| First Submitted : | November 7, 2022 |
| First Submitted that Met QC Criteria : | November 21, 2022 |
| First Posted : | November 22, 2022 |
| Last Update Submitted that Met QC Criteria : | May 6, 2024 |
| Last Update Posted : | May 7, 2024 |